查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1918126

近红外线成像市场－2026-2031年预测

Near Infrared Imaging Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

近红外线成像市场预计将从 2025 年的 1,446,540,000 美元成长到 2031 年的 2,910,381,000 美元，复合年增长率为 12.36%。

受技术进步、临床应用拓展和疾病负担加重的推动，近红外线成像市场正经历快速成长。这项利用近红外线产生精细影像的非破坏性成像技术，凭藉其独特的功能和良好的患者安全性，在多个医学领域中获得了广泛应用。慢性疾病（尤其是癌症）盛行率的上升，以及萤光剂研发的持续推进，正在推动市场扩张。

主要市场驱动因素

技术优势

近红外线成像技术具有诸多优势，这些都是其关键的成长要素。该技术是一种非电离成像方法，消除了辐射暴露的担忧，与X光和电脑断层扫描等其他技术相比，显着提高了患者安全性。这种安全性使得在临床需要时可以重复成像，而不会产生累积辐射风险。

这项技术能够实现疾病的早期检测，尤其适用于癌症等疾病，从而实现及时干预并改善患者预后。近红外线影像的非侵入性特性可减轻病患不适，降低併发症风险，并有助于提高病患对监测通讯协定的遵从性。这些综合优势使得近红外线成像技术对寻求更安全、更人性化的诊断和监测解决方案的临床医生越来越具有吸引力。

慢性病盛行率

慢性疾病（包括癌症、心血管疾病和神经系统疾病）的日益增多，显着推动了对近红外线成像等先进成像技术的需求，以辅助疾病的高阶管理和治疗方案的发展。慢性疾病负担沉重，2020年美国有8,100万人患有多种慢性疾病，显示其盛行率很高。在印度，超过50%的死亡是由慢性疾病造成的，目前有7,700万印度人患有糖尿病。预计到2045年，这一数字将增加至1.34亿。这些数据凸显了不断扩大的患者群体对近红外线成像所能提供的先进诊断和监测能力的需求。

肿瘤学应用

近红外线成像技术在肿瘤学领域得到了广泛应用，包括肿瘤定位、手术导航和疗效监测。萤光剂能够靶向特定癌细胞，在手术过程中提供即时回馈，并辅助实现肿瘤的彻底切除。全球癌症负担的日益加重进一步提升了对这项技术的需求。癌症是全球首要死因，2020年约有1,000万人死于癌症。此外，每年约有40万名儿童罹患癌症。这些数据表明，我们迫切需要先进的成像技术来提高手术精度和治疗效果。

微创手术和远端成像

近红外线成像技术具有非侵入性和便携的特点，使其成为即时诊断和远端成像应用的理想选择，这与医学领域向微创方法转变的趋势相契合。 2020年，在1,560万例美容手术中，有1,320万例采用微创手术，这充分体现了微创手术的普及程度。疫情期间，约95%的美国医疗机构提供远端医疗服务，凸显了医疗系统远距会诊的能力。由市场领导者开发的携带式成像设备进一步提高了远端成像解决方案的可近性，并拓展了该技术的潜在应用范围。

市场机会

慢性病日益普遍和人口老化为市场参与者提供了改进技术和提升患者体验的机会。新型近红外线萤光剂的研发和核准为标靶成像和诊断开闢了新的途径，拓展了该技术的临床效用和市场潜力。

市场限制

儘管近红外线成像市场成长前景强劲，但仍面临技术和营运方面的挑战。与超音波和磁振造影等其他成像方式相比，近红外线光在生物组织中的穿透深度有限。这项限制制约了深层解剖结构的影像，尤其是在组织增厚或体重指数（BMI）较高的患者中。

此外，近红外线成像缺乏标准化的通讯协定和成像流程，可能会阻碍其与现有医疗实践和成像工作流程的无缝衔接。随着市场日趋成熟，建立广泛认可的标准仍然是其发展面临的关键挑战。

区域趋势与发展

由于癌症病例不断增加、医疗保健支出不断增长、政府支持以及对技术创新的早期应用，预计北美在预测期内将占据显着的市场份额。 2020年，美国报告了1,603,844例新增癌症病例，并记录了602,347例癌症相关死亡病例。 Infiniti Electro-Optics、OmniVision和Karl Storz等主要市场市场领导的存在，正在推动区域市场的进一步发展。

近期发展凸显了技术的持续创新。 2022年8月，岛津公司开发了LuminousQuester NI系统，将高度灵活的相机硬体与使用者友善的软体结合，助力药物研发的进步。 2022年3月，Swift Medical公司推出了Swift Ray 1，这高光谱影像设备，能够提供全面的临床数据，用于监测和治疗皮肤及伤口状况。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 近红外线影像产品市场

  • 介绍
  • 近红外线萤光成像系统
  • 近红外线萤光和生物发光成像系统

6. 近红外线成像市场按应用领域划分

  • 介绍
  • 医学影像预科
  • 医学影像
  • 临床影像

7. 近红外线成像市场（按最终用户划分）

  • 介绍
  • 医院和诊所
  • 研究所
  • 其他的

8. 近红外线成像市场区域划分

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Near Infrared Imaging
  • Artinis Medical Systems
  • Ecole Polytenique Federale de Lausanne
  • OmniVision
  • Kaer Labs
  • Karl Storz
  • Rocket Reach
  • ThorLabs
  • Texas Instruments
  • Olympus Life Science

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615966

The near infrared imaging market is set to grow at a 12.36% CAGR, reaching USD 2910.381 million in 2031 from USD 1,446.540 million in 2025.

The near infrared imaging market is experiencing rapid growth driven by technological advantages, expanding clinical applications, and increasing disease burden. This non-destructive imaging technology, which creates detailed images using near-infrared wavelengths, is gaining prominence across multiple medical specialties due to its unique capabilities and patient safety profile. The convergence of rising chronic disease prevalence, particularly cancer, alongside ongoing research and development in fluorescent agents, is propelling market expansion.

Primary Market Drivers

Intrinsic Technological Benefits

Near infrared imaging offers numerous advantages that constitute a significant growth driver. The technology provides a non-ionizing imaging modality that substantially enhances patient safety compared to alternative techniques such as X-ray or CT scans, eliminating radiation exposure concerns. This safety profile enables repeated imaging as clinically necessary without cumulative radiation risks.

The technology facilitates early disease detection, particularly for conditions like cancer, enabling timely intervention and improved patient outcomes. The non-invasive nature of near infrared imaging reduces patient discomfort, lowers complication risks, and supports better patient compliance with monitoring protocols. These combined advantages make NIR imaging increasingly attractive for clinicians seeking safer, more patient-friendly diagnostic and monitoring solutions.

Chronic Disease Prevalence

The increasing prevalence of chronic diseases-including cancer, cardiovascular conditions, and neurological disorders-has driven substantial demand for advanced imaging technologies like near infrared imaging to support enhanced disease management and treatment planning. The chronic disease burden is considerable: 81 million Americans had multiple chronic ailments in 2020, demonstrating high prevalence. In India, chronic diseases account for more than 50% of all deaths, while diabetes affects 77 million Indians currently, with projections indicating growth to 134 million by 2045. These statistics underscore the expanding patient populations requiring advanced diagnostic and monitoring capabilities that NIR imaging can provide.

Oncology Applications

Near infrared imaging technology has found extensive applications in oncology, including tumor localization, surgical guidance, and treatment response monitoring. NIR fluorescent agents can target specific cancer cells, providing real-time intraoperative feedback and aiding complete tumor removal. The expanding cancer burden globally amplifies demand for these capabilities: cancer represents the leading cause of death worldwide, accounting for almost 10 million deaths in 2020, while approximately 400,000 children develop cancer annually. These figures highlight the critical need for advanced imaging technologies that improve surgical precision and treatment outcomes.

Minimally Invasive Surgery and Remote Imaging

Near infrared imaging's non-invasive nature and portability make it well-suited for point-of-care and remote imaging applications, aligning with healthcare's broader shift toward minimally invasive approaches. In 2020, 13.2 million minimally invasive cosmetic procedures were conducted out of 15.6 million total cosmetic procedures, demonstrating the scale of minimally invasive surgical adoption. During the pandemic, approximately 95% of U.S. healthcare centers offered telehealth services, highlighting the healthcare system's capacity for remote care delivery. Market leaders' development of portable imaging devices further enhances accessibility for remote imaging solutions, expanding the technology's potential applications.

Market Opportunities

The growing chronic disease prevalence combined with rising elderly populations provides opportunities for market players to enhance technology and patient experience. Development and approval of novel NIR fluorescent agents creates new opportunities for targeted imaging and diagnostics, expanding the technology's clinical utility and market potential.

Market Constraints

Despite robust growth prospects, the near infrared imaging market faces technical and operational challenges. Near-infrared light demonstrates limited penetration depth in biological tissues compared to alternative modalities like ultrasound or MRI. This limitation restricts visualization of deeper anatomical structures, particularly in patients with increased tissue thickness or elevated body mass index.

Additionally, the absence of standardized protocols and imaging procedures for NIR imaging can hinder seamless integration into existing healthcare practices and imaging workflows. Establishing widely accepted standards remains an important developmental priority for market maturation.

Regional Dynamics and Developments

North America is positioned to hold significant market share during the forecast period, supported by rising cancer cases, increased healthcare expenditure, government support, and early adoption of technological advancements. In 2020, 1,603,844 new cancer cases were reported in the United States, with 602,347 cancer-related deaths recorded. The presence of major market leaders including Infiniti Electro-Optics, OmniVision, and Karl Storz further accelerates regional market development.

Recent developments underscore ongoing innovation. In August 2022, Shimadzu developed the LuminousQuester NI system combining adaptable camera hardware with user-friendly software to advance drug discovery research. In March 2022, Swift Medical launched Swift Ray 1, a hyperspectral imaging device that wirelessly attaches to smartphones, providing comprehensive clinical data for skin and wound condition monitoring and treatment.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Near Infrared Imaging Market Segmentation

  • By Product
  • Near Infrared Flourescence Imaging Systems
  • Near Infrared Flourescence & Bioluminescence Imaging Systems
  • By Application
  • Pre-Medical Imaging
  • Medical Imaging
  • Clinical Imaging
  • By End-User
  • Hospitals & Clinics
  • Research Laboratories
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEAR INFRARED IMAGING MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Near Infrared Flourescence Imaging Systems
  • 5.3. Near Infrared Flourescence & Bioluminescence Imaging Systems

6. NEAR INFRARED IMAGING MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Pre-Medical Imaging
  • 6.3. Medical Imaging
  • 6.4. Clinical Imaging

7. NEAR INFRARED IMAGING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Research Laboratories
  • 7.4. Others

8. NEAR INFRARED IMAGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Near Infrared Imaging
  • 10.2. Artinis Medical Systems
  • 10.3. Ecole Polytenique Federale de Lausanne
  • 10.4. OmniVision
  • 10.5. Kaer Labs
  • 10.6. Karl Storz
  • 10.7. Rocket Reach
  • 10.8. ThorLabs
  • 10.9. Texas Instruments
  • 10.10. Olympus Life Science

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations